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 2 
Abstract 22 
Levels of activity are often affected in psychiatric disorders and can be core symptoms of 23 
illness. Advances in technology now allow the accurate assessment of activity levels but it 24 
remains unclear whether alterations in activity arise from shared risk factors for developing 25 
psychiatric disorders, such as genetics, or are better explained as consequences of the 26 
disorders and their associated factors. We aimed to examine objectively-measured physical 27 
activity in individuals with psychiatric disorders, and assess the role of genetic liability for 28 
psychiatric disorders on physical activity. Accelerometer data were available on 95,529 UK 29 
Biobank participants, including measures of overall mean activity and minutes per day of 30 
moderate activity, walking, sedentary activity, and sleep. Linear regressions measured 31 
associations between psychiatric diagnosis and activity levels, and polygenic risk scores 32 
(PRS) for psychiatric disorders and activity levels. Genetic correlations were calculated 33 
between psychiatric disorders and different types of activity. Having a diagnosis of 34 
schizophrenia, bipolar disorder, depression, or autism spectrum disorders (ASD) was 35 
associated with reduced overall activity compared to unaffected controls. In individuals 36 
without a psychiatric disorder, reduced overall activity levels were associated with PRS for 37 
schizophrenia, depression, and ASD. ADHD PRS was associated with increased overall 38 
activity. Genetic correlations were consistent with PRS findings. Variation in physical activity 39 
is an important feature across psychiatric disorders. Whilst levels of activity are associated 40 
with genetic liability to psychiatric disorders to a very limited extent, the substantial 41 
differences in activity levels in those with psychiatric disorders most likely arise as a 42 
consequences of disorder-related factors. 43 
 3 
Introduction 44 
Estimates suggest that physical inactivity causes 9% of premature mortality and 6-10% of 45 
the major non-communicable diseases worldwide[1]. Research consistently shows that 46 
individuals who engage in less physical activity report more stress[2], perform worse on 47 
cognitive tasks[3], are more likely to become depressed[4,5], and are at increased risk of 48 
cardiovascular disease, cancer, hypertension and diabetes[6]. Physical activity can be a core 49 
indicator of mental illness, from the increased activity seen in attention deficit hyperactivity 50 
disorder (ADHD) and mania to the decreased activity seen in depression and as part of the 51 
negative symptoms of schizophrenia[7–10]. Understanding the factors contributing to 52 
physical activity may assist in improving mental health, as well as reducing risk of chronic 53 
physical health conditions, many of which are known to be increased in individuals with 54 
severe mental illness[11]. 55 
Studies of physical activity have predominantly relied on self-report measures but this may 56 
lead to unreliable estimates of activity, especially for those with mental illness. A recent 57 
study reported marked differences when comparing accelerometer-measured activity 58 
between individuals with schizophrenia and controls, but not for self-reported activity[12]. 59 
This suggests that objective measures may better characterise physical activity in individuals 60 
with mental health disorders, and such approaches are being considered as part of clinical 61 
psychiatric care[13]. Research using accelerometers in the UK Biobank has shown physical 62 
activity to be a polygenic trait, with a heritability of around 23% in women and 20% in 63 
men[14].  64 
Physical activity in those with psychiatric disorders may be influenced by genetic liability to 65 
activity in the wider population, although it may primarily reflect disorder-specific factors. 66 
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Conversely, it is possible that genetic liability for psychiatric disorders influences physical 67 
activity, rather than activity differences being a consequence of the illness. Other factors 68 
known to be associated with both psychiatric disorders and physical activity, such as 69 
smoking, obesity, and social deprivation[15–17], may also confound this relationship and 70 
thus require investigation. 71 
A small number of studies have applied Mendelian Randomisation (MR) methodology[18] to 72 
examine the hypothesis that low physical activity might be a risk factor for developing 73 
psychiatric disorders, particularly depression and schizophrenia[19,20]. Some have reported 74 
findings consistent with the hypothesis that low physical activity might be causally related to 75 
depression, although one of the limitations of such studies is the lack of robust genetic 76 
instruments for MR analyses. Currently, the relationship between genetic liability to physical 77 
activity and psychiatric disorders is unclear. 78 
We aimed to assess the levels of objectively-measured physical activity in individuals with 79 
psychiatric disorders, and establish whether genetic liability for psychiatric disorders is 80 
associated with levels of physical activity in a population sample. We hypothesised that 81 
objective levels of physical activity in individuals with mental health disorders would differ 82 
from individuals without, and that there would be an association between polygenic risk for 83 






Study participants were from the population-based UK Biobank sample, a national cohort 89 
study of over 500,000 individuals aged 40-69 at the time of recruitment from one of 22 90 
assessment centres across the UK between 2006-2010[21]. Between 2013 and 2015, a 91 
subset of individuals was invited to participate in a study of device-measured physical 92 
activity (see S1 Fig for timeline of data collection). A random group of participants with a 93 
valid email address were invited, with the exception of those residing in the North West 94 
region, who were excluded due to concerns over participant burden. Of the 236,519 95 
individuals approached, 106,053 consented to participate[22]. Our study was conducted as 96 
part of UK Biobank project number 13310. Ethical approval for UK Biobank was granted by 97 
the North West Multi-Centre Ethics Committee and all participants provided written 98 
informed consent. All procedures contributing to this work comply with the ethical 99 
standards of the relevant national and institutional committees on human experimentation 100 
and with the Helsinki Declaration of 1975, as revised in 2008. 101 
 102 
Psychiatric diagnosis  103 
A diagnosis of schizophrenia, bipolar disorder, depression, ADHD, or an autism spectrum 104 
disorder (ASD) was defined from (i) self-report at the initial assessment, (ii) the mental 105 
health questionnaire[23] (Field ID: 20544), (iii) a diagnosis recorded on a hospital record, or 106 
(iv) a diagnosis recorded on a death record. Where individuals reported multiple diagnoses, 107 
they were included in each appropriate diagnostic group. For hospital and death records, 108 
participants were deemed to have a diagnosis when the following ICD-10 codes were 109 
present: F20 for schizophrenia, F30 or F31 for bipolar disorder, F32 or F33 for depression, 110 
F84 for ASD, and F90 for ADHD. We selected these disorders as altered activity can be a 111 
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prominent feature of the disorder and substantial GWAS data exist to allow us to test 112 
genetic hypotheses. 113 
 114 
Genetic data 115 
Genetic data were made available through UK Biobank, following imputation and quality 116 
control procedures that have been described elsewhere[24]. Participants were assayed at 117 
the Affymetrix Research Services laboratory using the UK Biobank Axiom or UK BiLEVE 118 
Axiom purpose-built arrays and imputation was performed using the Haplotype Reference 119 
Consortium panel[25]. Subsequent to imputation, we applied further quality control filters 120 
to select high-quality SNPs: minor allele frequency > 0.01, imputation score > 0.8, 121 
missingness < 0.05, and Hardy-Weinberg equilibrium p-value > 1x10-6. All genetic analyses 122 
were restricted to participants of European ancestry, confirmed through self-reported data 123 
and principal components[24] (UK Biobank Field IDs: 21000, 22009) as described in a 124 
previous study[26], and related individuals with a kinship score greater than 0.125 were 125 
removed at random.  126 
 127 
Genetic correlations 128 
We measured genetic correlations to examine the relationships between psychiatric 129 
disorder genetic risk and five classes of activity: overall, moderate, walking, sedentary, and 130 
sleep duration. We used Linkage Disequilibrium (LD) score regression[27,28] to calculate 131 
genetic correlations between each activity class and schizophrenia[29], bipolar disorder[30], 132 
major depressive disorder (MDD)[31], ADHD[32], and ASD[33].  133 
 7 
 134 
Polygenic risk scores 135 
PRSice[34] was used to derive polygenic risk scores (PRS) for schizophrenia, bipolar disorder, 136 
MDD, ADHD, and ASD from the same external discovery datasets used for the genetic 137 
correlations, following the methods used by the Psychiatric Genomics Consortium 138 
(PGC)[26,35]. PRS were calculated at six thresholds: p<5x10-8, 5x10-6, 5x10-4, 0.05, 0.1, 0.5. 139 
PRS were then standardised as Z-scores for each disorder, to allow for comparison between 140 
disorders.  141 
 142 
Accelerometer-measured physical activity 143 
Participants wore an Axivity AX3 tri-axial accelerometer for one week on the wrist of their 144 
dominant hand. The accelerometer captures activity at 100Hz with a dynamic range of ±8g. 145 
Data were processed by the accelerometer working group[22] in line with standard 146 
protocols, including calibration of devices, low-pass filtering to remove high frequency 147 
noise, and identification of non-wear periods[22,36–38]. A measure of overall physical 148 
activity was computed by partitioning the data into five second epochs and calculating the 149 
mean vector magnitude of each epoch to derive an overall mean acceleration (UK Biobank 150 
Field ID: 90012). 151 
We also used derived measures of time spent in sleep and physical activity behaviours. A 152 
recent study by Doherty et al.[14] classified the accelerometer activity being undertaken as 153 
sedentary, walking, moderate, or sleeping. In this study, participants in an independent 154 
sample wore wrist-worn accelerometers and a wearable camera for one week, in order to 155 
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map the accelerometer readings to an observable activity. Machine learning methods were 156 
then used to create a model that was able to classify accelerometer readings into a pre-157 
defined type of activity[14]. The researchers used these data to derive an overall probability 158 
of each participant engaging in each type of activity at any given time (Return ID: 1942). 159 
Overall level activity was standardised as a Z-score; moderate, walking, sedentary, and sleep 160 
were converted into minutes spent per day engaging in the activity type. Individuals with 161 
insufficient device wear time, poor device calibration and an overall mean activity Z score 162 
greater than 3 were excluded from analysis. 163 
Doherty et al.[14] conducted a GWAS on each of the activity subtypes; we used the 164 
summary statistics from these GWAS for LD score regression.  165 
 166 
Analysis 167 
All analyses were corrected for multiple comparisons using false discovery rate (FDR) at 168 
p<0.05.  169 
Linear regressions were conducted to measure the effect of diagnosis of schizophrenia, 170 
bipolar disorder, depression, ADHD and ASD on all types of activity: overall, moderate, 171 
walking, sedentary and sleep. Age, sex, and BMI were included as covariates in all models. 172 
Linear regressions were used to measure the associations between each disorder PRS and 173 
each type of activity, with age, sex, BMI, and genotyping array included as covariates in all 174 
PRS models. We routinely included the first five principal components as covariates. We also 175 
examined 20 principal components for each type of activity, and included any that were 176 
significantly associated with the relevant activity. This varied for each test and ranged from 177 
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one additional component for overall activity, to three additional components each for 178 
moderate and sedentary activity. 179 
PRS associations were conducted at the p<.05 threshold for the primary analyses; the 180 
remaining five thresholds were also tested for robustness. Individuals with a psychotic 181 
disorder, bipolar disorder, depression, ADHD or ASD diagnosis were excluded from all PRS 182 
analyses, leaving a total of 76,409 participants. None of the genome-wide association study 183 
(GWAS) discovery datasets we have used included the UK Biobank as a sample, but we are 184 
unable to definitively exclude an incidental degree of sample overlap. We note however 185 
that as calculated here, genetic correlations derived from  LD-score regression are robust to 186 
sample overlaps[28]. Moreover, all of the intercepts for our genetic correlations are below 187 
one, which is consistent with minimal sample overlap between the discovery GWAS and the 188 
target sample for PRS. 189 
In order to assess whether the relationship between PRS for psychiatric disorders and 190 
physical activity could be influenced by other confounders, we added alcohol use (Field ID: 191 
20414), cannabis use (Field ID: 20453), substance or behavioural addiction (Field ID: 20401), 192 
smoking status (Field ID: 20116), fluid intelligence (Field ID: 20016), and Townsend 193 
deprivation index (Field ID: 189) as additional covariates in the overall levels of activity PRS 194 
models. These data were available on 15,285 participants who had also completed the 195 
mental health questionnaire.  196 
To assess whether including BMI as a covariate could be a source of collider bias, we 197 




Age, sex, and diagnosis were available on 236,502 individuals who were invited to 201 
participate in the accelerometer study. Participation in the accelerometer study was 202 
significantly, yet minimally, associated with age at recruitment (OR=1.002; 95% CI=1.001, 203 
1.003; p=2.7x10-6), as well as with female sex (OR=1.14; 95% CI= 1.13, 1.16; p=4.7x10-59). 204 
Individuals with a diagnosis of schizophrenia, bipolar disorder, depression, ADHD, or ASD 205 
were significantly less likely to participate than individuals without a mental health disorder 206 
(OR= 0.95; 95% CI= 0.92, 0.98; p=0.002). 207 
A total of 95,744 participants were included in the study with high quality accelerometer 208 
data (56.4% female, mean age at recruitment [SD] 56.2 [7.8], see S2 Fig). 6,527 individuals 209 
were classified as having depression, 466 with bipolar disorder, 95 with schizophrenia, 87 210 
with ASD, and 53 with ADHD. 211 
 212 
Activity levels in psychiatric disorders 213 
Results are presented in Table 1, Figs 1 and 2. After correcting for multiple comparisons, 214 
schizophrenia was associated with reduced levels of overall activity, reduced time spent in 215 
moderate activity and longer sleep duration. Bipolar disorder was associated with reduced 216 
levels of overall activity, reduced time spent in moderate activity and walking, and longer 217 
sleep duration. Depression was associated with reduced levels of overall activity, reduced 218 
time spent in moderate activity and walking, and longer sleep duration. ASD was associated 219 
with reduced levels of overall activity, reduced time spent walking, and increased time spent 220 
in sedentary activity. ADHD was not associated with changes in any type of activity.221 
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Table 1. Association between activity and both psychiatric disorders and polygenic risk 222 
scores for psychiatric disorders in the UK Biobank. 223 
Columns represent the disorder, type of activity, effect size (beta), 95% confidence intervals, 224 
and FDR-corrected p-value of the association between either a diagnosis of the disorder or 225 
PRS for the disorder and level of activity. Effect size for overall activity corresponds to 226 
standard deviation change in activity, effect sizes for all other types of activity correspond to 227 




Psychiatric disorder Polygenic risk score 
Beta (95% CI) P-value Beta (95% CI) P-value 
Schizophrenia 
Overall -0.4 (-0.5, -0.2) 9.3x10-5 -0.01 (-0.01, -0.002) 0.01 
Moderate -14.8 (-25.1, -4.4) 0.01 0.4 (0.03, 0.8) 0.04 
Walking -5.8 (-18.5, 7.0) 0.50 1.0 (0.5 , 1.5) 9.6x10-5 
Sedentary -14.3 (-34.7, 6.1) 0.25 -1.2 (-2.0, -0.5) 3.0x10-3 
Sleep 42.2 (27.1, 57.3) 1.9x10-7 0.8 (0.3, 1.3) 0.01 
Bipolar 
disorder 
Overall -0.3 (-0.4, -0.2) 2.5x10-12 0.002 (-0.004, 0.01) 0.51 
Moderate -10.3 (-15.0, -5.7) 4.3x10-5 0.5 (0.1, 0.8) 0.02 
Walking -9.5 (-15.2, -3.7) 3.0x10-3 0.7 (0.2, 1.1) 0.01 
Sedentary -3.0 (-12.2, 6.3) 0.63 -0.8 (-1.5, -0.1) 0.04 
Sleep 22.7 (15.8, 29.5) 4.3x10-10 -0.01 (-0.5, 0.5) 0.96 
Depression 
Overall -0.2 (-0.2, -0.1) 1.5x10-51 -0.02 (-0.02, -0.01) 2.1x10-6 
Moderate -1.7 (-3.0, -0.4) 0.02 -0.6 (-0.9, -0.2) 0.01 
Walking -11.8 (-13.4, -10.2) 4.0x10-46 -0.8 (-1.2, -0.3) 3.0x10-3 
Sedentary 2.6 (0.1, 5.2) 0.07 0.1 (-0.6, 0.8) 0.83 
Sleep 11.9 (10.0, 13.8) 8.4x10-34 1.0 (0.4, 1.5) 1.8x10-3 
ADHD 
Overall 0.01 (-0.2, 0.2) 0.97 0.01 (0.003, 0.02) 0.01 
Moderate 5.2 (-8.7, 19.1) 0.58 0.6 (0.2, 0.9) 0.01 
Walking -4.8 (-21.8, 12.2) 0.66 -0.2 (-0.7, 0.2) 0.39 
Sedentary -3.0 (-30.3, 24.3) 0.87 -1.7 (-2.5, -1.0) 1.4x10-5 
Sleep -4.0 (-24.3, 16.2) 0.76 0.9 (0.4, 1.4) 3.0x10-3 
ASD 
Overall -0.4 (-0.6, -0.2) 1.8x10-5 -0.01 (-0.01, -0.002) 0.01 
Moderate -8.1 (-18.9, 2.7) 0.22 -0.1 (-0.5, 0.2) 0.54 
Walking -23.1 (-36.4, -9.9) 1.0x10-3 -0.6 (-1.0, -0.1) 0.02 
Sedentary 48.4 (27.1, 69.7) 2.7x10-5 1.9 (1.2, 2.6) 2.5x10-6 
Sleep -7.1 (-22.9, 8.7) 0.50 -0.8 (-1.4, -0.3) 0.01 
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Fig 1.  The effect size (beta) for associations between overall activity and diagnoses of, and 231 
PRS for, each psychiatric disorder. Error bars indicate 95% confidence intervals. A beta of 1 232 
is equivalent to a 1 standard deviation (SD) change in level of activity between individuals 233 
with and without a psychiatric disorder or per 1 SD increase in PRS. We excluded individuals 234 
with a psychiatric disorder for PRS analyses. 235 
 236 
Fig 2. Associations between type of activity in minutes and diagnoses of, and PRS for, each 237 
psychiatric disorder. Error bars indicate 95% confidence intervals. A beta of 1 is equivalent 238 
to a 1 standard deviation (SD) change in level of activity between individuals with and 239 
without a psychiatric disorder or per 1 SD increase in PRS. We excluded individuals with a 240 
psychiatric disorder for PRS analyses. 241 
 242 
Genetic Correlations 243 
Schizophrenia was genetically correlated with more time spent walking (rg=0.11, p=0.01), 244 
reduced time spent in a sedentary activity (rg=-0.09, p=0.02), and longer sleep duration 245 
(rg=0.07, p=0.04). Bipolar disorder was genetically correlated with greater moderate activity 246 
(rg=0.22, p=4x10-3) and more time spent walking (rg=0.11, p=0.05). MDD was genetically 247 
correlated with reduced overall activity (rg=-0.1, p=0.01) and reduced walking (rg=-0.1, 248 
p=0.02). ASD was significantly genetically correlated with greater sedentary activity (rg=0.25, 249 
p=3x10-3) and reduced sleep duration (rg=-0.2, p=0.01). Regression coefficients for all 250 
comparisons are displayed in Fig 3 and full results are presented in S1 Table. 251 
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Fig 3. Genetic correlation matrix displaying the correlation coefficient (rg), with square colour 252 
indicating direction of effect. Black text indicates correlation coefficients significant at FDR-253 
corrected p<.05, grey text indicates non-significant correlations. 254 
 255 
Polygenic Risk Scores 256 
Results are presented in Table 1, Figs 1 and 2. In individuals without a mental health 257 
disorder, after correcting for multiple comparisons, schizophrenia PRS was associated with 258 
reduced levels of overall activity, increased time spent in moderate activity, increased time 259 
spent walking, reduced time spent in sedentary activity, and longer sleep duration. Bipolar 260 
disorder PRS was associated with increased time spent in moderate activity, increased time 261 
spent walking, and reduced time spent in sedentary activity. MDD PRS was associated with 262 
reduced levels of overall activity, reduced time spent in moderate activity, reduced time 263 
spent walking, and longer sleep duration. ADHD PRS was associated with increased levels of 264 
overall activity, increased time spent in moderate activity, reduced time spent in sedentary 265 
activity, and longer sleep duration. ASD PRS was associated with reduced levels of overall 266 
activity, reduced time spent walking, increased time spent in sedentary activity, and shorter 267 
duration of sleep. 268 
 269 
PRS associations were consistent across the thresholds tested (S2 Table - S6 Table). The 270 
proportion of variance explained by PRS for each type of activity are demonstrated in S3 Fig. 271 
The effect sizes for schizophrenia, bipolar disorder, and ADHD PRS in association with 272 
overall levels of activity remained consistent after covarying for alcohol use, cannabis use, 273 
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substance or behavioural addiction, smoking status, fluid intelligence, and Townsend 274 
deprivation index . However, effect sizes were reduced for MDD and ASD PRS when these 275 
covariates were included (S7 Table). Results were consistent between models that included 276 
and excluded BMI as a covariate (S8 Table).  277 
 278 
Discussion 279 
In this study, we found levels of objectively-measured physical activity to be altered in UK 280 
Biobank participants with a diagnosis of schizophrenia, bipolar disorder, depression, or ASD. 281 
We observed several significant genetic correlations between psychiatric disorders and 282 
types of activity, suggesting that the genetic architecture of physical activity is shared, to a 283 
small extent, with the genetic architecture of psychiatric disorders. Increased PRS for 284 
schizophrenia, bipolar disorder, MDD, ADHD, and ASD were associated with significant, yet 285 
minimal, changes in levels of physical activity in individuals without mental health disorders. 286 
 287 
Activity levels in psychiatric disorders 288 
We found that individuals with schizophrenia, bipolar disorder, depression and ASD had 289 
reduced levels of overall physical activity in comparison to individuals without a mental 290 
health diagnosis, consistent with previous research demonstrating reduced levels of 291 
subjectively-measured activity in psychiatric disorders[7–9,39]. Our results expand upon 292 
existing findings by demonstrating these effects in a sample that is larger than has been 293 
reported previously, and by using objective methods to capture activity. Additionally, we 294 
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present novel findings that individuals with psychiatric disorders show different patterns of 295 
activity, including reduced moderate activity and longer sleep duration in individuals with 296 
schizophrenia, bipolar disorder, and depression, and increased levels of sedentary activity in 297 
individuals with depression and ASD. Previous research has suggested that disruption to 298 
circadian rhythm, measured by smaller differences between the most active and least active 299 
periods of the day, is associated with increased likelihood of depression and bipolar 300 
disorder[39]. Our results support and extend these findings by demonstrating a reduced 301 
pattern of activity with longer sleep duration in individuals with these disorders. The 302 
disruption in physical activity observed in this study could arise either from disorder-related 303 
factors such as symptoms or medication side-effects, or from risk factors for the disorders. 304 
Together these findings suggest that disrupted activity may be an important aspect of 305 
psychiatric illness. 306 
ADHD diagnosis, however, was not associated with level of physical activity. Between 40 and 307 
60% of children with ADHD continue to show symptoms in adulthood[40], thus it is possible 308 
that many participants with an ADHD diagnosis may be asymptomatic by the time of data 309 
collection. Alternatively, our result may reflect the fact that the UK Biobank is a cohort of 310 
individuals aged over 40, who may be less likely to have received a diagnosis of ADHD due to 311 
changes in the awareness of the disorder over time[41].  312 
 313 
Genetic liability for psychiatric disorders 314 
In individuals without a mental health disorder, genetic liability for schizophrenia, MDD, 315 
ADHD, and ASD was significantly associated with the overall level of physical activity. We 316 
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also observed several associations between PRS and levels of subtypes of activity, including 317 
greater levels of moderate activity with increased PRS for schizophrenia, bipolar disorder, 318 
and ADHD.  These findings are consistent with the hypothesis that physical activity is one of 319 
the behaviours that is influenced by genetic risk for psychiatric disorders in individuals 320 
without mental health disorders. However, both the estimated effect sizes of PRS 321 
associations and the genetic correlations were small, suggesting that the differences we 322 
observed in levels of activity in individuals with psychiatric disorders are the result of 323 
manifesting the disorders per se, rather than reflections of genetic vulnerability to them. 324 
Such factors may be secondary, for example the use of psychotropic medication[42] or 325 
could be symptoms of the disorder itself. The associations between overall levels of activity 326 
and MDD and ASD PRS were attenuated after controlling for alcohol use, cannabis use, 327 
substance addiction, smoking, cognition, and deprivation, further suggesting that non-328 
genetic factors may have a stronger effect on levels of activity than PRS. This has important 329 
consequences for the physical health of those with psychiatric disorders, particularly as 330 
these individuals are known to be at greater risk of numerous physical health conditions[11] 331 
and early mortality[43], which may in part be due to reduced levels of activity. Further 332 
research aiming to understand why physical activity is affected in psychiatric disorders is 333 
necessary to address and improve physical and mental health outcomes of individuals with 334 
these disorders. 335 
 336 
Strengths and limitations 337 
We were unable to exclude the possibility of an overlap of participants between training 338 
and target samples when calculating PRS. However, the genetic correlation analysis, for 339 
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which non-overlapping samples is not a requirement, supports our PRS findings. Case 340 
overlap between the discovery GWAS and our target sample (UK Biobank) would lead to 341 
overestimation of the PRS effect sizes for any PRS associations that are driven by psychiatric 342 
diagnoses. As the effect sizes we observed are already trivial, any overestimation in effect 343 
size would not in any important way alter the conclusions. A strength of our study is the 344 
substantial sample size, allowing greater power to detect small genetic effects. However, it 345 
is important to note that our sample is a population-based cohort and the limited number of 346 
psychiatric cases within UK Biobank means we were under-powered to measure the 347 
influence of genetic risk in those with psychiatric illness. Individuals with mental health 348 
disorders are known to be under-represented in the UK Biobank and those that are included 349 
tend to be a more highly functioning group than people with the disorders as a whole[44]. 350 
Thus, the differences in levels of activity in individuals with psychiatric disorders are likely to 351 
be underestimated in our study. 352 
Obtaining accelerometer data in a sufficiently-powered sample of individuals with 353 
psychiatric disorders is a notable challenge. Nevertheless, future research would benefit 354 
from the study of objectively-measured activity in individuals with mental health disorders, 355 
particularly given findings demonstrating substantial discrepancies between self-report and 356 
accelerometer-measured activity[12]. 357 
 358 
Conclusions 359 
We found novel evidence of association between schizophrenia, MDD, ADHD, and ASD PRS 360 
and accelerometer-assessed physical activity in the UK Biobank. Levels of physical activity 361 
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were significantly reduced in UK Biobank participants with a diagnosis of schizophrenia, 362 
bipolar disorder, depression and ASD, emphasising the need for clinical intervention to 363 
address levels of physical activity in these populations. Furthermore, several significant 364 
genetic correlations were observed with subtypes of physical activity, most notably between 365 
ASD and sedentary activity, ASD and sleep duration, and bipolar disorder and moderate 366 
activity. Overall, our findings indicate a weak to modest sharing of liability to the psychiatric 367 
disorders and types of activity we have tested, suggesting that the much more substantial 368 
differences in levels of activity seen in individuals with the psychiatric disorders are mainly 369 
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